Seth A Spector

University of Miami Miller School of Medicine, Miami, Florida, United States

Are you Seth A Spector?

Claim your profile

Publications (15)39.09 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: Importance: The American Board of Surgery In-Training Examination (ABSITE) is designed to measure progress, applied medical knowledge, and clinical management; results may determine promotion and fellowship candidacy for general surgery residents. Evaluations (EVAL) are mandated by the ACGME but are administered at the discretion of individual institutions, and are not standardized. It is unclear if ABSITE and EVAL form a reasonable assessment of resident performance. Objective: To determine whether favorable evaluations correlate with ABSITE performance. Design: Cross-sectional design. Setting: A single university-based General Surgery Training Program. Participants: Preliminary and categorical residents in postgraduate year (PGY) 1 -5 who took the ABSITE from 2011-2014 (n=150). Exposure: EVAL overall performance and subset EVAL performance in the following categories: Patient Care, Technical Skills, Problem Based Learning, Interpersonal and Communication Skills, Professionalism, Systems Based Practice, and Medical Knowledge. Outcome: Primary outcomes included passing (≥ 30th percentile) the ABSITE, and ranking in the top 30% of scores at our institution. Results: The study population was comprised of PGY 1 (n=44), PGY 2 (n=31), PGY 3 (n=26), PGY 4 (n=25), PGY 5 (n=24). EVAL had less variation then ABSITE (Std Dev=5.06 vs 28.82). Neither Annual EVAL nor EVAL subset scores were significantly associated with passing the ABSITE (n=102) or receiving a top 30% score (n=45). There was no difference in mean EVAL score between those who passed vs failed the ABSITE or between those who received a top 30% score vs those who did not. There was no correlation between annual EVAL and ABSITE percentile (r2= 0.014, p=0.148), percent correct unadjusted for PGY level (r2= 0.019, p=0.093), or percent correct adjusted for PGY level (r2= 0.429, p=0.913). Conclusions and Relevance: Favorable evaluations do not correlate with ABSITE scores, nor do they predict passing. Evaluations do not show much discriminatory ability. It is unclear if individual resident evaluations and ABSITE scores fully assess competency in residents, or allow comparisons to be made across programs. Creation of a uniform evaluation system that encompasses the necessary subjective feedback from faculty with the objective measure of the ABSITE is warranted.
    The 2015 Association of VA Surgeons Annual Meeting, Miami Beach, FL; 05/2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The laparoscopic repair offers clear advantages in recurrent inguinal hernias after open herniorrhaphy. Less clear is the role of laparoscopy for recurrences after previous laparoscopic inguinal herniorrhaphies. In this paper, we present our experience with both laparoscopic and open inguinal hernia repair of laparoscopic recurrences. All patients who had undergone repair of recurrences after previous laparoscopic hernia repair from July 2004 to July 2007 were included in this study. Charts were reviewed for all these patients. Six patients were diagnosed with 7 recurrent inguinal hernias after laparoscopic repairs. All the initial laparoscopic repairs, except for one, were total preperitoneal (TEP) with the placement of lightweight polypropylene mesh. The average time from the initial repair to the diagnosis of recurrence was 20 months (range 3-84). Four of the 7 recurrences were treated with a laparoscopic approach. The other three recurrences were repaired in an open fashion as per the preoperative plan. In 2 of the laparoscopic cases, the peritoneal flap was not able to cover the mesh, so a tissue-separating mesh with fibrin sealant was utilized to cover the myopectineal orifice. No intra- or postoperative complications were recorded. There were no recurrences at an average follow-up of 14 months (range, 11-17). Laparoscopic repair can be offered to those patients with a recurrence after a previous laparoscopic repair. Further studies comparing laparoscopic repair versus open repair of recurrences after laparoscopic inguinal hernia repair will be helpful in defining the best approach when encountering these recurrences.
    Journal of Laparoendoscopic & Advanced Surgical Techniques 09/2009; 19(4):475-8. DOI:10.1089/lap.2008.0408 · 1.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Parastomal hernias are among the most frustrating and incapacitating complications of permanent colostomies. Because the traditional surgical options of primary repair with or without ostomy repositioning have led to disappointing results, the use of mesh is indicated, especially in the setting of multiple recurrences. After laparoscopic lyses of adhesions, the colostomy is pushed against the lateral abdominal wall, and a bovine pericardium graft is gently stretched and draped over the colostomy (the Sugarbaker technique). Transfascial sutures and tacks are placed along the perimeter of the mesh and around the colon to prevent small bowel herniation. The patient developed a small seroma postoperatively, which resolved spontaneously. At his 17-month follow-up, the patient had no evidence of recurrence, he was pain free, and he was satisfied with his cosmetic results. Although several studies indicate the feasibility and efficacy of synthetic permanent mesh repair, the concerns of mesh infection, erosion, and ostomy obstruction still persist. The authors suggest parietalizing the bowel and using a biologic mesh.
    American journal of surgery 12/2008; 196(5):715-9. DOI:10.1016/j.amjsurg.2008.07.012 · 2.29 Impact Factor
  • Article: Crack Cecum

    Journal of the American College of Surgeons 11/2008; 207(4):612. DOI:10.1016/j.jamcollsurg.2008.02.039 · 5.12 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the new era of resident work hour restrictions and an emphasis on minimally invasive surgery, experience in performing open biliary surgery is diminishing. We sought to review our resident operative experience to determine if it appears adequate for a well-trained general surgeon. The case logs of the General Surgery, Oncology, and Trauma/Emergency General Surgery (EGS) services were reviewed for a 1-year period. All biliary procedures that included the potential for gallbladder or bile duct surgery were reviewed. We performed 745 laparoscopic cholecystectomies last year on our General Surgery, Oncology, and Trauma/EGS services. Conversion to open procedure was 4.5% (16/364) on our elective services and 6% (23/381) on our Trauma/EGS services. Effective clearance of common bile duct stones performed retrograde by endoscopy and transhepatically by interventional radiology limited our residents' experience performing common bile duct surgery for stones to 13 performed laparoscopically and 10 performed open. Other operations that included open cholecystectomies and common bile duct procedures were pancreatico-duodenectomy (87), biliary bypass (22), biliary resection/reconstruction (20), hepatic lobectomy (48), sphincteroplasty and ampullectomy (6). The small number of conversions from laparoscopic to open cholecystectomies and the few common bile duct explorations performed for stone disease would be inadequate to train our six categorical surgical residents to perform open cholecystectomies and common bile duct procedures without a training program that augments this by providing a strong hepato-biliary-pancreatic experience. Programs without a strong hepato-biliary-pancreatic program should review their residents' operative experience.
    Journal of Surgical Research 11/2007; 142(2):246-9. DOI:10.1016/j.jss.2007.03.073 · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A phase II trial to evaluate neoadjuvant (NAD), surgery and adjuvant (AD) combination chemotherapy without radiation therapy (RT) for patients with esophageal adenocarcinoma staged with endoscopic ultrasound and CT as T3N1 was carried out. Thirty-three eligible patients were enrolled. NAD therapy was administered in two 49-day cycles and included cisplatin, floxuridine, paclitaxel and leucovorin. Esophageal resection was performed followed by AD therapy. Thirty-three patients initiated NAD therapy; 10 experienced grade 3 and 4 toxicities, which included leucopenia, fatigue, nausea, diarrhea and stomatitis. Additionally, 16 patients experienced grade 1 and 2 hematologic and non-hematologic toxicities. Fifteen patients were down-staged, of whom five were T2, seven were T1, and three had nodal disease with no evidence of residual cancer in the esophageal bed. Fifteen patients remained T3, and two showed progressive disease. Thirty-two patients proceeded to surgery and 30 were resected. Although all resected patients were eligible for AD therapy, 15 did not receive it either because of patient refusal or surgeon recommendation. Fifteen patients received AD therapy: nine who had remained T3 and six who had down-staged. Three patients experienced grade 3 and 4 toxicities similar to those in NAD therapy. Six patients had grade 1 and 2 toxicities. Kaplan-Meier estimates of overall survival at 1, 3 and 5 years were 73% (95% CI: 58-88%), 52% (95% CI: 34-69%) and 29% (95% CI: 13-45%), respectively. Median survival was 42 months. Deletion of RT may safely allow for more aggressive chemotherapy and increase chances of survival. The results need to be confirmed in a randomized phase II or larger phase III trial.
    Japanese Journal of Clinical Oncology 09/2007; 37(8):590-6. DOI:10.1093/jjco/hym076 · 2.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Screening mammography has increased the number of patients diagnosed with ductal carcinoma-in-situ (DCIS) in the past 20 years. The Florida Cancer Data System is the largest single source incident cancer registry in the United States. We analyzed this registry to determine the changing incidence and treatment patterns for DCIS. Patients with DCIS from 1981 to 2001 were identified. Age-adjusted rate, descriptive statistics, and incidence of future DCIS and invasive breast cancer were calculated. A total of 23,810 DCIS patients were identified. The age-adjusted rate of DCIS has risen from 2.4 to 27.7 per 100,000 women between 1981 and 2001. Median age was 64 years; 85% of patients were white, 6.6% African American, and 7.5% Hispanic. Median tumor size was .9 cm. Forty-seven percent of patients had breast-conserving therapy (BCT). Half of the 53% of patients undergoing mastectomy underwent a modified radical mastectomy. Eight percent received no surgical treatment. Sentinel lymph node biopsy was used in 2.7% of patients who underwent a mastectomy. After BCT, 37.5% received adjuvant radiotherapy, and only 13% were treated with hormonal therapy. The incidence of DCIS has risen dramatically with the advent of screening mammography. Increasing numbers of these patients are treated with BCT, although a large proportion are still treated with mastectomy, in some cases combined with axillary dissection. Sentinel lymph node biopsy and tamoxifen are important components of therapy, the use of which is slowly increasing in the treatment of DCIS.
    Annals of Surgical Oncology 06/2007; 14(5):1638-43. DOI:10.1245/s10434-006-9316-1 · 3.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Prognostication of truncal and retroperitoneal soft tissue sarcomas has traditionally been predicated on tumor location and grade. To compare outcomes for patients with retroperitoneal or truncal sarcomas. Retrospective analysis of a prospective cancer data registry from 1977 to 2004 was performed and outcomes were determined. The study group numbered 312 patients (median age 58 years, 54% male, 56% Caucasian, 14% black, 29% Hispanic). The most common tumor types were liposarcoma (35.9%), leiomyosarcoma (30.1%), and malignant fibrous histiocytoma (MFH) (19.5%). Tumor distributions were retroperitoneal (38.9%), pelvic (24.7%), abdominal (18.6%) and thoracic (17.9%). Median overall survival was 74 months. Operative resection was undertaken in 89.4% of cases and multiple surgeries (range 2-5) in 42.2%. Negative resection margins were obtained in 72.7% of patients. Univariate analysis comparing retroperitoneal versus truncal location demonstrated no significant differences in survival. Survival was improved in lower grade tumors (P < 0.02). Liposarcoma and fibrosarcoma were associated with improved survival (P < 0.0001). Multivariate analysis of pre-treatment variables showed increasing age, grade, histopathology (leiomyosarcoma and MFH) and metastasis to be associated with worse outcomes. Multivariate analysis of the treatment variables showed that surgery and negative resection margins were associated with improved survival (P < 0.001). No advantage for chemoradiotherapy could be demonstrated. Successful operative resection can confer prolonged disease-free survival and cure for truncal and retroperitoneal sarcomas. Histological subtype, not location, is predictive of long-term survival. Future studies should focus on histological subtype rather than tumor location for truncal and retroperitoneal sarcomas.
    Annals of Surgical Oncology 04/2007; 14(3):1114-22. DOI:10.1245/s10434-006-9255-x · 3.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Control of liver hemorrhage may present a daunting clinical scenario. Use of liver packing techniques is highly effective to control bleeding but can result in significant recurrent bleeding with pack removal. Such bleeding is particularly a problem when large portions of the hepatic parenchymal surface and Glisson's capsule have been disrupted. We describe, herein, our approach to hepatic packing in scenarios where a large component of hepatic capsular disruption has occurred. Use of a non-stick bowel bag is employed on the disrupted liver surface, which, when removed, will not result in liver rebleeding. This technique has been used successfully in the management of five cases of severe liver injury with extensive capsular disruption. Familiarity with such an approach may facilitate management of similar liver injuries.
    Journal of Gastrointestinal Surgery 03/2005; 9(2):284-7. DOI:10.1016/j.gassur.2004.11.003 · 2.80 Impact Factor

  • Journal of the American College of Surgeons 01/2005; 199(6):991-3. DOI:10.1016/j.jamcollsurg.2004.07.024 · 5.12 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Without Abstract
    Annals of Surgical Oncology 02/2004; 11(S2). DOI:10.1007/BF02524218 · 3.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Without Abstract
    Annals of Surgical Oncology 02/2004; 11(2). DOI:10.1007/BF02524219 · 3.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tumors with oncocytic differentiation may occur in a variety of organs, but are extremely rare in the biliary system. Intraductal oncocytic papillary neoplasms (IOPNs) were first described in the pancreas to differentiate a rare subset of pancreatic neoplasm from the intraductal papillary mucinous neoplasms (IPMNs). IOPN of the extrahepatic biliary tree has not been previously described. We describe the first case of an intraductal oncocytic papillary neoplasm at the bifurcation of the common hepatic duct in a 52-year-old white male with a two-year history of intermittent biliary obstruction.
    The American surgeon 02/2004; 70(1):55-8. · 0.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We performed a Phase II trial to evaluate the use neoadjuvant (NAD) and adjuvant (AD) combination chemotherapy (CT) without radiation therapy (RT), for advanced esophageal adenocarcinoma. The eligibility criteria include T3 disease, by Computed Tomography and/or endoscopic ultrasounds, and ECOG performance 0–1. The CT cycles were as follow: Cisplatin 100 mg/m2 on day one, Taxol 125 mg/m2 on day 28, FUDR 80 mg/kg and Leucovorin 500 mg/m2 over 24 hours on days 2 and 29; FUDR 150 mg/kg and Leucovorin 500 mg/m2 on days 14, 21, 42 and 49. Two cycles were given before and after surgery. Survival evaluated by Kaplan Meier. 33 patients enrolled in the study from 1998–2000 with transmural (T3) disease on initial EUS. 28 (85%) patients completed NAD, 14 (45%) patients received AD. 19 (48%) patients developed grade I/II toxicity, and 15 patients (42%) developed grade III/IV toxicity, namely, neutropenia, stomatitis, fatigue and 1 expired prior to surgery. 30 of 32 patients (82%) were resectable (24 transhiatal and 6 transthoracic). The average length of stay was 11.8 days with average of 2.3 days in the ICU. The mean ASA score was 2.58 with mean operative time of 4.6 hrs and mean EBL of 565 ml. Operative morbidity and mortality rates were 37% and 3% respectively. There were 5 anastomotic leaks, 12 pulmonary complications and 1 operative death. Of the 28 patients who completed NAD 68% demonstrated improved dysphagia and 67% gained weight or were unchanged. On pathologic evaluation, 13 were T3, 7 were T2, 8 were T1 and 2 had only micrometastases to the nodes with no residual cancer in the esophagus. Of 33 patients enrolled, 16 (48%) are alive with median follow up of 42 months (range 5–60). 13 patients (39%) have no evidence of disease, 1 has local-regional recurrence, 1 has brain metastasis and 1 with a resected adrenal metastasis. 17 patients have expired, 12 disease related with distant metastasis (brain, bone, lung, liver), 3 non-disease related and 2 were unresectable. The Kaplan Meier estimate of 3-year survival is 50% (95% CI: 32%–68%). This regimen of combination chemotherapy for locally advanced esophageal adenocarcinoma is safe and comparable with those regimens that contain RT. Omission of RT may allow for a more aggressive CT, and reduction in the local complications post-surgery.
    Journal of Surgical Research 10/2003; 114(2):277. DOI:10.1016/j.jss.2003.08.022 · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cystadenomas are usually found in the extra-hepatic bile ducts in conjunction with multilocular cysts in the liver. Cystadenoma of the gallbladder itself is a rare finding, cited only once in the literature as the cause of extrinsic obstruction of the common bile duct (5). In this report, we describe the endoscopic retrograde cholangiopancreaticographic (ERCP) detection of intrinsic obstruction of the cystic duct and common bile duct by such a tumor in a 47-yr-old woman.
    International Journal of Gastrointestinal Cancer 02/2003; 34(2-3):151-5. DOI:10.1385/IJGC:34:2-3:151

Publication Stats

161 Citations
39.09 Total Impact Points


  • 2003-2009
    • University of Miami Miller School of Medicine
      • Department of Pathology
      Miami, Florida, United States
  • 2004-2007
    • University of Miami
      • Department of Surgery
      كورال غيبلز، فلوريدا, Florida, United States